Search - tctmd.com

Displaying 221 - 240 of 433

Sort: Relevancy | Date

News Daily News

Aortic Regurgitation Risk, Consequences Vary Between First-Generation TAVR Devices

Caitlin E. Cox

August 07, 2014

News Industry News

Sorin Group Announces FDA Approval of Solo Smart – The Next Evolution in Tissue Valve Technology

July 29, 2014

News Industry News

St. Jude Medical Announces CE Mark Approval and First Use of the FlexAbility Ablation Catheter

July 22, 2014

News Industry News

Miracor Medical Systems begins European launch of its next-generation PICSO® Impulse System

July 22, 2014

News Industry News

The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission

July 07, 2014

News Industry News

Edwards Receives FDA Clearance For Advanced Noninvasive Monitoring System

June 30, 2014

News Daily News

High-Dose Edoxaban as Effective as Warfarin for Stroke Prevention in A-fib

Yael L. Maxwell

June 27, 2014

News Features

Advocacy Group Blasts Mobile Cardiovascular Screening Company for ‘Unethical’ Practices

Yael L. Maxwell

June 27, 2014

News Features

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

June 24, 2014

News Features

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

June 18, 2014

News Daily News

SYMPLICITY HTN-2: Renal Denervation Safe, Effective at 3 Years

Yael L. Maxwell

June 11, 2014

News Industry News

St. Jude Medical and CardioMEMS Announce FDA Approval of the CardioMEMS Heart Failure Management System

May 28, 2014

News Industry News

FDA Approves First Implantable Wireless Device with Remote Monitoring to Measure Pulmonary Artery Pressure in Certain Heart Failure Patients

May 28, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Yael L. Maxwell

May 22, 2014

News Industry News

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

May 22, 2014

News Conference News EuroPCR 2014

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Yael L. Maxwell

May 22, 2014

News Industry News

Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published in European Heart Journal

May 22, 2014

News Industry News

POST-IT Clinical Registry Demonstrates Importance of St. Jude Medical Fractional Flow Reserve Technology at EuroPCR 2014

May 22, 2014

News Industry News

Mounting Scientific Evidence Supports Role of Power Plate® Whole Body Vibration in Lowering Blood Pressure

May 15, 2014

Advertisement

Aortic Regurgitation Risk, Consequences Vary Between First-Generation TAVR Devices

Sorin Group Announces FDA Approval of Solo Smart – The Next Evolution in Tissue Valve Technology

St. Jude Medical Announces CE Mark Approval and First Use of the FlexAbility Ablation Catheter

Miracor Medical Systems begins European launch of its next-generation PICSO® Impulse System

The Medicines Company Receives Market Authorization Renewal for Angiox® (Bivalirudin) from the European Medicines Agency and the European Commission

Edwards Receives FDA Clearance For Advanced Noninvasive Monitoring System

High-Dose Edoxaban as Effective as Warfarin for Stroke Prevention in A-fib

Advocacy Group Blasts Mobile Cardiovascular Screening Company for ‘Unethical’ Practices

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

SYMPLICITY HTN-2: Renal Denervation Safe, Effective at 3 Years

St. Jude Medical and CardioMEMS Announce FDA Approval of the CardioMEMS Heart Failure Management System

FDA Approves First Implantable Wireless Device with Remote Monitoring to Measure Pulmonary Artery Pressure in Certain Heart Failure Patients

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published in European Heart Journal

POST-IT Clinical Registry Demonstrates Importance of St. Jude Medical Fractional Flow Reserve Technology at EuroPCR 2014

Mounting Scientific Evidence Supports Role of Power Plate® Whole Body Vibration in Lowering Blood Pressure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content